[News Viscovery]
Vienna / Austria, 14 June 2016 Data mining and data visualization specialist Viscovery Software GmbH reports 2015 was the best fiscal year in the history of the company. Both revenues and equity ratio increased significantly, with the net profit margin rising to 37%. The overall share of consulting services in total revenues was about 15%.
This successful result was mainly due to business successes in life sciences which, in cooperation with parent company Biomax Informatics AG, continued to develop well in 2015. Besides ongoing project business with the Centre of Expertise for Chronic Organ Failure (CIRO+) in the Netherlands, substantial revenues resulted from new business in the biotech sector, in particular in the USA.
In addition to revenues from joint-offering projects, local project services and software maintenance, income was produced by new license customers, such as Mead Johnson in the USA, the Transport Accident Commission in Australia, the National Institute for Environmental Studies in Japan, the IT solution provider SHI International in the UK, and the Ministry of Finance in Singapore.
Numerous universities worldwide purchased Viscovery SOMine licenses for research, including the King’s College London, Vilnius University, Universiti Sains Malaysia, and Shizuoka University in Japan.